Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3358 results

Sort By:

Clinical Outcomes and Major Adverse Events in Patients Treated with Physician-Modified Fenestrated and Branched Stent Grafts

Study ID: NCT06526676
Start Date: 2025-12
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Cook Alpha TX2 Stent Graft, Cook Zenith TX2, and Cook Zenith Fenestrated Stent Graft

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Percutaneous Embolectomy, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

Study ID: NCT06453876
Start Date: 2025-06-01
End Date: 2029-10-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

210

Intervention / Treatment

Ultrasound assisted Thrombolysis

Percutaneous Embolectomy

Heparin

Sponsor

Jesper Kjaergaard

Source: clinicaltrials.gov

Share:
Add to list

SERS Sensor Based on CHA Reaction for EGFR Mutation Typing in Advanced Lung Cancer

Study ID: NCT06772376
Start Date: 2026-05-01
End Date: 2026-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

SERS sensor based on CHA reaction

Sponsor

Fuzhou General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Open-Label, Pilot Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis

Study ID: NCT06941376
Start Date: 2025-07
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Methotrexate (MTX)

AZthitrine (Don't)

Adalimumab

Infliximab

Tocilizumab

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma

Study ID: NCT06357676
Start Date: 2025-05-09
End Date: 2029-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

Biospecimen Collection

Bone Marrow Biopsy

Computed Tomography

Echocardiography

FDG-Positron Emission Tomography

Glofitamab

Ibrutinib

Magnetic Resonance Imaging

Obinutuzumab

Sponsor

OHSU Knight Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Developing an SGM Smoking Cessation Intervention With Community Partners

Study ID: NCT06602076
Start Date: 2025-09
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

50

Intervention / Treatment

ECHO (Empowering Our Community & Health Outcomes)

Sponsor

University of Oklahoma

Source: clinicaltrials.gov

Share:
Add to list

Toripalimab With Chemotherapy for Sinus Cancer

Study ID: NCT06940180
Start Date: 2025-10
End Date: 2029-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Tripleimab

Carboplatin

Docetaxel

Radiation Therapy

Cisplatin

Sponsor

Glenn J. Hanna

Source: clinicaltrials.gov

Share:
Add to list

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

Study ID: NCT06682780
Start Date: 2025-06-05
End Date: 2029-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

320

Intervention / Treatment

LM-2417

Docetaxel

Toripalimab/Tirelizumab

Carboplatin

Nirparb

Lenvew

Sponsor

LaNova Medicines Limited

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants

Study ID: NCT06934980
Start Date: 2025-06-18
End Date: 2025-11-21
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Microneedle Device

Sponsor

Incyte Corporation

Source: clinicaltrials.gov

Share:
Add to list

T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.

Study ID: NCT06474676
Start Date: 2025-09-30
End Date: 2032-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

Cyclophosphamide

T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list